JPRN-UMIN000005095招募中1 期
Chemotherapy for advanced pancreatic cancer with combined usage of gemcitabine and GSK3beta-inhibiting medicines - GSK COCKTAI
1)Multidisciplinary Cancer Center,Kanazawa Medical University Hospital 2)Department of Surgical Oncology, Kanazawa Medical University Hospital0 个研究点目标入组 6 人开始时间: 2011年2月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) A patient who has a past history of hypersensitivity to the medicines used. 2) A pregnant woman, a woman of possible pregnancy, or a lactating woman 3) Miscellaneous patients who are judged inadequate for enrollment by an attending physician
研究者
相似试验
进行中（未招募）
3 期
Adjuvant Chemotherapies in Resectable Pancreatic CancerACTRN12605000361606Australasian Gastro-Intestinal Trials Group (AGITG)1,090
进行中（未招募）
1 期
Treatment of pancreatic adenocarcinoma with the combinationof carboplatin and velparibEUCTR2014-003785-24-HUzsoki Utcai Kórház
进行中（未招募）
不适用
ltrasound-assisted treatment of inoperable pancreatic cancer. ”Behandling av inoperabel kreft i bukspyttkjertelen ved å kombinere kontrast ultralyd og gemcitabin under sonoporering”Patients with inoperable pancreatic cancer.Histologically verified, locally advanced (nonresectable Stage II/III) or metastatic (Stage IV) adenocarcinoma of the pancreas. The patients must be ambulatory with an ECOG performance status 0-2.EUCTR2010-024289-24-NOHelse Bergen HF, Haukeland Unversity Hospital10
招募中
2 期
Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnPPancreatic AdenocarcinomaNCT05268692Kochi University500
进行中（未招募）
不适用
Radio-/Chemotherapie des PankreaskarzinomsRadio-/Chemotherapy of pancreas carcinoma - PaCaEUCTR2009-011968-11-DETechnische Universität Dresden